Celltrion Pharm, Inc. (KOSDAQ:068760)
48,400
+1,400 (2.98%)
May 21, 2026, 3:30 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 2.08 trillion as of May 20, 2026. Its market cap has increased by 1.45% in one year.
Market Cap
2.08T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
80.57
Stock Price
48,400.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.08T, an increase of 3,030.99%. That is a compound annual growth rate of 18.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 2.08T | -19.25% |
| Dec 30, 2025 | 2.57T | 4.33% |
| Dec 30, 2024 | 2.47T | -35.41% |
| Dec 28, 2023 | 3.82T | 44.48% |
| Dec 29, 2022 | 2.64T | -43.45% |
| Dec 30, 2021 | 4.67T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 6.19T |
| Hanmi Pharm. | 5.48T |
| Hanall Biopharma | 2.35T |
| GC Biopharma | 1.53T |
| Daewoong Pharmaceutical | 1.53T |
| Chong Kun Dang Pharmaceutical | 1.05T |
| DongKook Pharmaceutical | 965.37B |
| Daewoong | 832.13B |